Vir Biotechnology, Inc
Vir Biotechnology, Inc. is a San Francisco-based company dedicated to harnessing the power of the immune system to develop innovative therapies that address significant unmet medical needs, particularly in infectious diseases and cancer. With proprietary technology platforms, including next-generation antibodies and PRO-XTEN protease-releasable masking technology, Vir focuses on advancing therapeutic candidates from concept to clinic, notably in chronic hepatitis delta, COVID-19, and Ebola.
Led by a seasoned management team, Vir Biotechnology is committed to delivering transformative medicines for patients worldwide. The company actively seeks to engage talented individuals who share its mission of improving patient outcomes through groundbreaking immunological advancements.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.